Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses

European Journal of Pediatrics

Volumn 167, Issue 2, 2008, Pages 203-209

  Malinowska, Marcelina ^a   Jakóbkiewicz Banecka, Joanna ^a   Kloska, Anna ^a   Tylki Szymańska, Anna ^b   Czartoryska, Barbara ^c   Piotrowska, Ewa ^a   Węgrzyn, Alicja ^a   Wȩgrzyn, Grzegorz ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Diagnostic tools; Hair dysmorphology; Mucopolysaccharidoses; Scanning electron microscopy

Indexed keywords

DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; KERATAN SULFATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HAIR; HAIR ANALYSIS; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; MAJOR CLINICAL STUDY; MALE; MAROTEAUX LAMY SYNDROME; MORPHOLOGY; MORQUIO SYNDROME; MUCOPOLYSACCHARIDOSIS; PRIORITY JOURNAL; SANFILIPPO SYNDROME; SCANNING ELECTRON MICROSCOPY;

EID: 37549032485     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-007-0462-7     Document Type: Article

References (19)

1. Bosch A, Heard JM (2003) Gene therapy for mucopolysaccharidosis. Int Rev Neurobiol 55:271-296
2. Brady RO (2006) Enzyme replacement for lysosomal diseases. Annu Rev Med 57:283-296
3. Brooks DA, Muller VJ, Hopwood JJ (2006) Stop-codon read-through for patients affected by a lysosomal storage disorder. Trends Mol Med 12(8):367-373
4. Charan RK, Nauer G, Wagner U, Klabuschnig A, Lubec G (1986) Physicochemical hair conformation of patients with Sanfilippo disease type IIIA. Padiatr Padol 21(3):249-256
5. Crump IA, Danks DM (1971) Simple method for cutting transverse sections of hair. Comments on shape of hair in Hurler and Sanfilippo syndromes. Arch Dis Child 46(247):383-386
6. Ellinwood NM, Vite CH, Haskins ME (2004) Gene therapy for lysosomal storage diseases: the lessons and promise of animal models. J Gene Med 6(5):481-506
7. Harmatz P, Giugliani R, Schwartz I, Guffon N, Teles EL, Miranda MC, Wraith JE, Beck M, Arash L, Scarpa M, Yu ZF, Wittes J, Berger KI, Newman MS, Lowe AM, Kakkis E, Swiedler SJ; MPS VI Phase 3 Study Group (2006) Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study. J Pediatr 148(4):533-539
8. Hinek A, Wilson SE (2000) Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. Am J Pathol 156(3):925-938
9. Kloska A, Bohdanowicz J, Konopa G, Tylki-Szymańska A, Jakóbkiewicz-Banecka J, Czartoryska B, Liberek A, Wȩgrzyn A, Wȩgrzyn G (2005) Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human alpha-L-iduronidase (laronidase, Aldurazyme). Am J Med Genet A 139(3):199-203
10. Lubec G, Nauer G (1988) Infrared spectroscopy studies on the conformation of human hair. Padiatr Padol 23(2):101-108
11. Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga A, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A (2006) A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 8(8):465-473
12. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3421-3452
13. Piotrowska E, Jakóbkiewicz-Banecka J, Barańska S, Tylki-Szymańska A, Czartoryska B, Wȩgrzyn A, Wȩgrzyn G (2006) Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 14(7):846-852
14. Roberts AL, Thomas BJ, Wilkinson AS, Fletcher JM, Byers S (2006) Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA. Pediatr Res 60(3):309-314
15. Schiffmann R, Brady RO (2002) New prospects for the treatment of lysosomal storage diseases. Drugs 62(5):733-742
16. Silengo M, Valenzise M, Sorasio L, Ferrero GB (2002) Hair as a diagnostic tool in dysmorphology. Clin Genet 62(4):270-272
17. Sperling LC (2001) Hair and systemic disease. Dermatol Clin 19(4):711-726
18. Teschler-Nicola M, Killian W (1982) Observations on hair shaft morphology in mucopolysaccharidoses. J Ment Defic Res 26(Pt 3):193-202
19. Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF (2004) Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase). J Pediatr 144(5):581-588